Clinical features and outcome in patients with glomerulonephritis and antineutrophil cytoplasmic autoantibodies

Nephron

Volumn 64, Issue 2, 1993, Pages 182-188

  Gans, R O B ^a   Kuizinga, M C ^a   Goldscmeding, R ^a   Assmann, K ^a   Huysmans, F T M ^a   Gerlag, P G G ^a   Donker, A J M ^a   Hoorntje, S J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Antineutrophil cystoplasmic autoantibodies; Glomerulonephritis; Myeloperoxidase; Proteinase 3; Rapidly progressive glomerulonephritis; Wegener's granulomatosis

Indexed keywords

AUTOANTIBODY; ENZYME ANTIBODY; GRANULOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT; MYELOPEROXIDASE; PROTEINASE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FATALITY; FEMALE; GLOMERULONEPHRITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION COMPLICATION; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; SCORING SYSTEM; STAINING; SYMPTOM; WEGENER GRANULOMATOSIS;

EID: 0027225628     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000187311     Document Type: Article

References (0)